Atria Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
4,276
+72
| +2% | +$23.5K | 0.02% | 886 |
|
|
2025
Q1 | $1.14M | Buy |
4,204
+893
| +27% | +$241K | 0.01% | 946 |
|
|
2024
Q4 | $779K | Buy |
3,311
+166
| +5% | +$39.1K | 0.01% | 1118 |
|
|
2024
Q3 | $865K | Buy |
3,145
+1,387
| +79% | +$381K | 0.01% | 1049 |
|
|
2024
Q2 | $427K | Buy |
+1,758
| New | +$427K | 0.01% | 1383 |
|